THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

15 ديسمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference

21 نوفمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update

09 نوفمبر 2022 15:15:00 بحسب Nasdaq GlobeNewswire

Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

19 سبتمبر 2022 15:10:00 بحسب Nasdaq GlobeNewswire